.Merck defeats earnings desires, increases purchases expectation on strong need for top medications like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Forecasts as Keytruda Sales Increase BloombergMerck Supply: Pharma Titan Posts Sturdy Outcomes, Yet Outlook Drops Short Investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats profit as well as sales requirements among Keytruda asset, but offers mixed full-year outlook MarketWatch.